ClinicalTrials.gg
Sign In

BiologicalDrug

Autologous Anti-BCMA-CAR-TCRz/4-1BB-expressing T-lymphocytes CART-BCMA clinical trials

studies test it
3
open now
1
in phase 3
0
first study started
2015

Keep track of what changes. Save the Autologous Anti-BCMA-CAR-TCRz/4-1BB-expressing T-lymphocytes CART-BCMA studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

CART-BCMA
3

Studies by the year they started

3 studies that test it; most in 2015 (1)

Studies that test Autologous Anti-BCMA-CAR-TCRz/4-1BB-expressing T-lymphocytes CART-BCMA, by start year
YearStudies
20151
20211
20241

By phase

A phase 1/2 study counts in both.

Phase 1
3

What it is tested for

Each study’s main condition, where its own words name it.

Multiple Myeloma
2
Renal Insufficiency
1

Who runs them

Industry 1 · Other 2

Shanghai Simnova Biotechnology Co.,Ltd. (1) · University of Pennsylvania (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)

Often tested with

Tested in the same studies.

Cyclophosphamide (1) · HUCART19 (1)

Studies

Open first, then newest update. How each study uses Autologous Anti-BCMA-CAR-TCRz/4-1BB-expressing T-lymphocytes CART-BCMA is read from its arms, and is right about nine times in ten.

Testing it · 3